Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Trade Show, Webcast

ReCode Therapeutics to Present Preclinical Data from mRNA-Based Program for Primary Ciliary Dyskinesia at the 2021 PCD on the Move Virtual Scientific Conference


ReCode Therapeutics (the "Company"), a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery platform, today announced preclinical data from the Company's inhaled mRNA-based molecular therapy program for primary ciliary dyskinesia will be presented in an oral and poster presentation at the 2021 PCD on the Move Virtual Scientific Conference, which is being held virtually on Thursday, August 5, 2021 at 11:45 am ET.

Archived replays of each presentation will be made available on the Company's website following the presentations.

About ReCode Therapeutics

ReCode Therapeutics is an integrated genetic medicines company developing disease-modifying therapeutics using powerful LNP delivery technology to target organs and tissues beyond the liver. The Company's pipeline includes lead programs for patients with life-limiting genetic respiratory diseases, including cystic fibrosis and primary ciliary dyskinesia. The Company is leveraging its proprietary LNP platform and nucleic acid technologies and utilizing systemic and direct delivery for mRNA-mediated replacement and gene editing/correction in target cells, including stem cells. For more information, visit www.recodetx.com and follow us on Twitter @ReCodeTx and LinkedIn.


These press releases may also interest you

at 23:17
The food recall warning issued on September 10, 2021 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Erie Meat...

at 21:00
Agra Ventures Ltd. ("AGRA" or the "Company") , a growth-oriented and diversified company focused on the international cannabis industry, announces that it has changed its auditor from Dale Matheson Carr-Hilton Labonte LLP ("Former Auditor") to...

at 20:00
Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced...

at 20:00
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced...

at 19:25
Pfizer Inc. and BioNTech SE announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the FDA grant Emergency Use Authorization (EUA) for a...

at 18:32
The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the USA, and its strategic partners at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) continue to make a...



News published on 30 july 2021 at 16:15 and distributed by: